ROCKVILLE, Md. (AP) ¿ Development-stage drug maker EntreMed Inc. reported a third-quarter profit Monday on lower costs and expenses.

The company earned $84,914, or zero cents per share, compared with a loss of $3.4 million, or 4 cents per share, during the same period a year prior. Revenue, mainly from royalties, rose 5 percent to $3.7 million from $3.5 million.

Research and development expenses were cut in half to $2.3 million during the quarter.

The company had just over $10 million in cash and short-term investments as of Sept. 30.

Shares of EntreMed fell 15 cents, or 12 percent, to $1.12 in morning trading. The stock has traded between 15 cents and $1.53 over the last 52 weeks.
Copyright 2009 Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

If you liked this article you might like

What's Behind the Surge in Energy Stocks

Hillary Clinton Says Prosecuting Individuals is Key to Wall Street Reform